![](/img/cover-not-exists.png)
352 Final Results of the First in Man Trial of MK4827, a Poly (ADP-ribose) Polymerase (PARP) Inhibitor with Antitumor Activity in BRCA Carriers and Sporadic Cancer Patients
Sandhu, S.K., Wilding, G., Schelman, W.R., Omlin, A., Kreischer, N., Carpenter, C., Iannone, R., Kaye, S., de-Bono, J.S., Wenham, R.M.Volume:
48
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(12)72150-0
Date:
November, 2012
File:
PDF, 77 KB
english, 2012